Cargando…
Betahistine in the treatment of Ménière’s disease
Ménière’s disease and related disease of the vestibular system are common and debilitating. Current therapy is multi-modal and includes drug therapy and lifestyle adaptations. Unfortunately many of the drugs used in treatment (particularly those used to control nausea) are sedative and hamper the pr...
Autores principales: | Lacour, Michel, van de Heyning, Paul H, Novotny, Miroslav, Tighilet, Brahim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655085/ https://www.ncbi.nlm.nih.gov/pubmed/19300572 |
Ejemplares similares
-
Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches
por: Tighilet, Brahim, et al.
Publicado: (2018) -
Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease
por: Casani, Augusto Pietro, et al.
Publicado: (2018) -
Hearing function after betahistine therapy in patients with Ménière's disease()
por: Seyed Tootoonchi, Seyed Javad, et al.
Publicado: (2015) -
Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine
por: Teggi, R., et al.
Publicado: (2014) -
Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience
por: Monzani, D., et al.
Publicado: (2012)